Skip to content

Clinical trials

Epilepsies, Partial trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsies, Partial Country / region: Russia Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20052
20062
20071
20081
20092
20101
20111
20121
20131
20161
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
UCB Pharma3
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Supernus Pharmaceuticals, Inc.2
Bial - Portela C S.A.1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Marinus Pharmaceuticals1
Novartis1
SK Life Science, Inc.1
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsies, Partial17
Epilepsy11
Seizures10
Drug Resistant Epilepsy1
Epilepsy, Complex Partial1

Trials

Showing 26 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.